Locations:
Search
Researching the biological basis for why treatment is or is not effective
Unraveling the TNFA receptor 2/dendritic cell axis
Older Psoriasis Patients May Experience Quicker Transition
Genetic polymorphisms and response to TNFα blockers
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
The potential for safer therapies
Patient reported outcomes differentiate between remission and low disease activity in PsA
Co-management increases opportunities for research and education
Defect in myosin binding may explain why a significant percentage of patients do not adequately respond to anti-TNF therapy
Study finds significant histologic differences between TNFi-induced psoriasis and idiopathic psoriasis
Patients with minimal disease activity report better physical and mental health as well as less fatigue
Advertisement
Advertisement